Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2 359 million in Q3 FY26
30-जनवरी-2026
डाउनलोड पीडीएफ़
Strides Pharma
Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2 359 million in Q3 FY26